Recently published findings from a phase 1 clinical trial (NCT03298672) of fosgonimeton (Athira Pharma) show that the treatment was safe and well tolerated in patients with Alzheimer disease (AD). These results add support to the development of the treatment, previously known as ATH-1017, as a novel therapeutic for people with AD and dementia.1,2 Investigators included […]

As humans, we are allowed a lot of room to make mistakes. After all, this is pretty much how we learn and grow over time, right? Now, while that’s accurate, we, at the same time, can’t really skirt past some obligations in play, a notable one being our obligation to move forward under all circumstances. […]

What You Should Know: – DarioHealth Corp., a provider of global digital therapeutics (DTx), announced it has entered into a $30M multi-year, strategic agreement with Sanofi U.S., an innovative global healthcare company. The multi-year, $30 million-dollar agreement will help accelerate commercial adoption of Dario’s full suite of digital therapeutics and drive the expansion of digital health […]